Skip to main content Skip to main menu
UF Health University of Florida
Division of Nephrology, Hypertension & Renal Transplantation Department of Medicine in the College of Medicine
Request an Appointment
Wai L Lau

Wai L Lau, M.D.

Clinical Assistant Professor

Department: MD-NEPHROLOGY
Business Phone: (352) 273-8821

On This Page

About Wai L Lau

I am an assistant professor in the University of Florida Division of Nephrology, Hypertension and Renal Transplantation, within the areas of internal medicine and nephrology, and I am board certified in both. I specialize in the treatment and research of glomerular diseases, and I am committed to improving patient care by providing access to novel treatment options via clinical studies for glomerular diseases.

I completed medical school in 1995 at State University of New York Health Science Center and completed my internal residency at the University of Massachusetts Medical Center, where I subsequently completed a nephrology fellowship. I also completed a glomerular fellowship at Columbia University Medical Center.

I am the principle investigator of several studies here at the UF for IgA glomerulonephritis and FSGS. Patient participation in these clinical studies gives greater access to treatments that are otherwise limited and suboptimal. It is my joy being able to provide patients, often younger, get treatment to improve their lives.

When not practicing at UF Health Nephrology – Shands Hospital, I enjoy keeping up with my personal interests: hiking, cooking and photography.

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Nephrology
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Nephrology

Areas of Interest

  • Glomerulonephritis
  • Lupus Nephritis

Research Profile

Areas of Interest

  • Glomerulonephritis
  • lupus nephritis

Grants

  1. VX19-NEN-801: A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin

    Role:
    Principal Investigator
    Funding:
    VERTEX PHARMACEUTICALS

  2. A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)

    Role:
    Principal Investigator
    Funding:
    VERA THERAPEUTICS

  3. A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease

    Active

    Role:
    Principal Investigator
    Funding:
    VERTEX PHARMACEUTICALS

  4. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function (The ALIGN Study)

    Role:
    Principal Investigator
    Funding:
    CHINOOK THERAPEUTICS

  5. An Open Label Extension (OLE) Study to Evaluate The Efficacy and Safety of Nefecon Treatment in Patients with IGA Nephropathy Who Have Completed Study NEF-301

    Role:
    Principal Investigator
    Funding:
    CALLIDITAS THERAPEUTICS

  6. A multi-center, randomized, double-blind, placebo-controlled, parallel group, phase III study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients

    Role:
    Principal Investigator
    Funding:
    NOVARTIS PHARMACEUTICALS CORP

  7. A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL, ACTIVE-CONTROL STUDY OF THE EFFECTS OF SPARSENTAN, A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, ON RENAL OUTCOMES IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

    Role:
    Principal Investigator
    Funding:
    IQVIA Holdings via TRAVERE THERAPEUTICS

  8. A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF NEFECON IN PATIENTS WITH PRIMARY IGA NEPHROPATHY AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE (NefIgArd)

    Role:
    Principal Investigator
    Funding:
    MEDPACE via CALLIDITAS THERAPEUTICS

Education

  1. Glomerular Fellowship

    Columbia University Medicial Center

  2. Nephrology Fellowship

    University of Massachusetts Medical Center

  3. Internal Medicine Residency

    University of Massachusetts Medical Center

  4. Medical Degree

    State University of New York Health Science Center

Contact Details

Phones:
Business:
(352) 273-8821
Addresses:
Business Mailing:
PO Box 100224
 GAINESVILLE FL 32610
Business Street:
PO Box 100224
 GAINESVILLE FL 32610